Sanyan Wu - China Medical Company Secretary
| CHSYFDelisted Stock | USD 0.93 0.00 0.00% |
Executive
Ms. Wu Sanyan is the Company Secretary of the Company. Ms. Wu joined the Group in 2009 and currently serves as Director of the Legal Department. Ms. Wu is primarily responsible for overseeing the legal and regulatory compliance matters of the Group . The responsibilities of Ms. Wu since her joining of the Group include advising on compliance of laws and regulations applicable to the Group. Considering that Ms. Wu is familiar with the Group matters and has extensive experience in compliance matters, the Board believes Ms. Wu is a qualified candidate for the position of company secretary since 2017.
| Age | 40 |
| Tenure | 7 years |
| Phone | 852 2369 7678 |
| Web | https://www.cms.net.cn |
China Medical Management Efficiency
The company has return on total asset (ROA) of 0.1324 % which means that it generated a profit of $0.1324 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.243 %, meaning that it generated $0.243 on every $100 dollars invested by stockholders. China Medical's management efficiency ratios could be used to measure how well China Medical manages its routine affairs as well as how well it operates its assets and liabilities.China Medical System has accumulated 573.81 M in total debt with debt to equity ratio (D/E) of 0.13, which may suggest the company is not taking enough advantage from borrowing. China Medical System has a current ratio of 3.1, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist China Medical until it has trouble settling it off, either with new capital or with free cash flow. So, China Medical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like China Medical System sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for China to invest in growth at high rates of return. When we think about China Medical's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Mary MD | ANI Pharmaceuticals | N/A | |
| Raymond Vre | Dr Reddys Laboratories | 52 | |
| Sauri Gudlavalleti | Dr Reddys Laboratories | 42 | |
| Shannon Buggy | Cronos Group | 54 | |
| Greg McDonald | SNDL Inc | N/A | |
| Vivek Mittal | Dr Reddys Laboratories | N/A | |
| Ran Meir | Teva Pharma Industries | N/A | |
| Dov Bergwerk | Teva Pharma Industries | N/A | |
| David JD | Teva Pharma Industries | 61 | |
| Anna Shlimak | Cronos Group | 38 | |
| Bhethanabottla Phanimitra | Dr Reddys Laboratories | N/A | |
| Advocate Baron | Teva Pharma Industries | N/A | |
| Amanda Morgan | Lantheus Holdings | N/A | |
| Anil Namboodiripad | Dr Reddys Laboratories | 54 | |
| Hussein Arkhagha | Hikma Pharmaceuticals PLC | N/A | |
| Thomas Rowland | ANI Pharmaceuticals | 57 | |
| Arye Weigensberg | Cronos Group | 41 | |
| Sandeep Poddar | Dr Reddys Laboratories | N/A | |
| Christopher Mutz | ANI Pharmaceuticals | 53 | |
| Vikki Conway | Teva Pharma Industries | 52 | |
| Alberto ParederoQuiros | SNDL Inc | 51 | |
Management Performance
| Return On Equity | 0.24 | |||
| Return On Asset | 0.13 |
China Medical System Leadership Team
Elected by the shareholders, the China Medical's board of directors comprises two types of representatives: China Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of China. The board's role is to monitor China Medical's management team and ensure that shareholders' interests are well served. China Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, China Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Yanling Chen, CFO, Vice-Pres and Executive Director | ||
| Wai Wong, Chief Technical Officer | ||
| Kong Lam, Founder, Chairman of The Board, CEO and Member of Nomination Committee | ||
| Sanyan Wu, Company Secretary | ||
| Hongbing Chen, COO, Vice-President, Director of Sales and Marketing and Executive Director |
China Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is China Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.24 | |||
| Return On Asset | 0.13 | |||
| Profit Margin | 0.36 % | |||
| Operating Margin | 0.37 % | |||
| Current Valuation | 3.84 B | |||
| Shares Outstanding | 2.45 B | |||
| Shares Owned By Insiders | 49.55 % | |||
| Shares Owned By Institutions | 19.25 % | |||
| Price To Earning | 8.10 X | |||
| Price To Book | 1.71 X |
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Consideration for investing in China Pink Sheet
If you are still planning to invest in China Medical System check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the China Medical's history and understand the potential risks before investing.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |